You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
R3: A Smart Attachment for Improving Adherence and Usage of Metered Dose Inhalers
SBC: Cognita Labs, LLC Topic: NIDADESCRIPTION (provided by applicant): Respiratory illnesses continue to be on the rise1-4, in particular, COPD alone impacts nearly 210 million globally 6. Metered Dose Inhaler (MDI) is the most common mechanism to deliver medicine, and is used by the patients for both maintenance and rescue medications. It is well established that regular use of the medications minimizes long-term damage to the lu ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Enhanced recovery of disqualified donor organs using image-guided machine perfusion
SBC: ORGAN SOLUTIONS, LLC Topic: NIDDKDESCRIPTION (provided by applicant): In the United States alone, 76,000 lives are claimed by liver disease every year. Transplantation is currently the only established treatment, but there is a critical shortage of donor organs. More than 60% of candidates wait over a year to receive a transplant, the majority becoming too ill to tolerate the procedure. These numbers could be improved dramatical ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Stabilization of Therapeutic Peptides by Non-Perturbative Chemical Modification
SBC: VERAQUEL TECHNOLOGIES, INC. Topic: NIDDKDESCRIPTION (provided by applicant): Type 2 diabetes is a particularly debilitating disease and is endemic for a large proportion of the world's population. The unmet challenges in disease management are the lack of long-term efficacy in reducing hyperglycemia and the inability to stop progression. Glucagon-like peptide-1 (GLP-1), a natural gut hormone, provides a platform for therapeutics to ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
High-Purity Peptide Libraries without Chromatographic Separation
SBC: VERAQUEL TECHNOLOGIES, INC. Topic: NIEHSDESCRIPTION (provided by applicant): The market for peptide and protein products is 30 billion annually and continues to grow. Automated solid phase peptide synthesis (SPPS) is a mainstay of modern medicinal research, and has been used on micromole up tometric ton industrial scale. Peptide drugs such as Exenatide, a GLP-1 analogue and a life-saver to many type-2 diabetes patients, and Fuzeon for ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
EKO Approach To Find Small Molecules That Perturb Protein Protein Interaction
SBC: Small Molecule PPI Mimics LLC Topic: NIGMSDESCRIPTION (provided by applicant): One of the major new frontiers in the pharmaceutical industry is the design of small molecules to perturb protein-protein interactions PPIs. Many medicinally validated protein targets involve PPIs, but the methods available to discover small molecules that perturb these are, on aggregate, inadequate. Small Molecule PPI Mimics LLC owns intellectual property cove ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
A novel 3D cell culture human uterine contractility assay for high-throughput scr
SBC: CHEMOSEN3D INC Topic: NICHDDESCRIPTION (provided by applicant): Several disorders in reproductive medicine are results of changes in smooth muscle contractile activity. Increased myometrial contraction can lead to preterm labor, which affects 12% of the US population. However, the mechanisms involved in the transition from uterine quiescence to contractility at the onset of labor are not well-known. As a result, the managem ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Protein Bound RNA Sequencing
SBC: BIOO SCIENTIFIC CORPORATION Topic: NHGRIDESCRIPTION (provided by applicant): Protein-RNA interactions make a profound contribution to the regulatory logic of post- transcriptional control of gene expression. Tools to decipher this intricate layer of molecular interactions on a global scale are coming to the forefront of molecular biology and genomics. The most wide spread methodology to examine interactions of RNA binding proteins (RBPs ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Multi-functional particles for stem cell isolation and expansion
SBC: PROGENITEC INC Topic: NIMHDESCRIPTION (provided by applicant): The objective of this STTR Phase I proposal is to develop novel multi-layer microparticles and demonstrate their feasibility to isolate and expand stem cells for medical research and therapeutic applications. In recentyears, stem cells have been used in a wide variety of applications, including cell- based therapies, drug screening, and models to understand the ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health